A new study conducted by the American Cancer Society highlights that while quitting smoking can reduce cancer risk at any age, quitting before age 45 can eliminate almost all cancer risk.
Quitting smoking between the ages of 45 and 54 was still associated with a significant 78% reduction in cancer risk, while quitting between the ages of 55 and 64 was associated with a 56% reduction. Titled "Association of Whole-Life Initiation and Smoking Cessation with Cancer Mortality in 410,000 U.S. Adults prospective Study," the study of more than 400,000 Americans found that smokers were three times more likely than nonsmokers to die from tobacco-related cancers.
However, quitting smoking before age 45 reduced the risk by 89 percent, while for those who quit before age 35, the risk was completely eliminated, the researchers reported. On the other hand, quitting smoking between 45 and 54 years of age was still associated with a significant 78% reduction in risk, while quitting between 55 and 64 years of age was associated with a 56% reduction.
Similarly, the age at which smoking started also had an impact on cancer risk, the team found. Those who started smoking before the age of 18 had at least three times the risk of dying from cancer, while those who started smoking before the age of 10 had four times the risk.
Tobacco use behavior after cancer diagnosis
Another recent study, published in the Annals of Internal Medicine, found that quitting smoking after a lung cancer diagnosis can prevent cancer recurrence and prolong life. The study, "Quitting smoking after Diagnosis and Reducing the Risk of Lung Cancer Progression and Death," was conducted by researchers at the World Health Organization's specialized cancer agency, the International Agency for Research on Cancer, in collaboration with N.N. Russian National Oncology Medical Research Center in Blokhin. The research team recruited 517 adults from two sites in Moscow, Russia, who were current smokers at the time of diagnosis of early-stage non-small cell lung cancer.
At the beginning of the study, participants were interviewed to determine their medical history and lifestyle, including tumor characteristics, as well as their patterns of tobacco use. Each participant was followed for an average of seven years each year to record any changes in their smoking behavior.
Of the 517 lung cancer patients who smoked at the time of diagnosis, less than half (44.5 percent) quit smoking and few recurred. Patients who quit smoking lived longer overall (6.6 vs. 4.8 years), lived longer without lung cancer (5.7 vs. 3.9 years) and had a slower rate of disease progression (7.9 vs. 6 years).
Given these findings, the team concluded that quitting smoking after being diagnosed with early-stage NSCLC may slow disease progression and reduce mortality.

